Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
876 studies found for:    Open Studies | "Blood Coagulation Disorders"
Show Display Options
Rank Status Study
21 Not yet recruiting Determination of Fibrin Activity in Plasma on STA-R® Prototype
Conditions: Blood Coagulation Disorders;   Thrombotic Disorders;   Hemorrhagic Disorders
Interventions: Other: Routine hemostasis tests;   Other: Fibrin structure (FS);   Other: Thromboelastography (TEG);   Other: Specialized hemostasis tests
22 Not yet recruiting The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin
Condition: Blood Coagulation Disorders
Intervention: Drug: Voltaren ophtha 0.1%
23 Not yet recruiting Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months
Condition: Blood Coagulation Disorders
Intervention: Biological: Plasma
24 Recruiting Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures
Conditions: Blood Coagulation Disorders;   Hemorrhage
Intervention: Biological: Fresh frozen plasma transfusion
25 Recruiting Transfusion of Plasma Prior to Invasive Procedures Pilot Trial (TOPPIT)
Condition: Blood Coagulation Disorders
Intervention: Biological: Frozen plasma
26 Recruiting ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals
Condition: Blood Coagulation Disorders
Intervention: Device: ROTEM sigma
27 Recruiting A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients
Conditions: End Stage Renal Failure on Dialysis;   Complication of Dialysis;   Blood Coagulation Disorders
28 Recruiting Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
Conditions: Blood Coagulation Disorders;   Atrial Fibrillation;   Thrombosis of Left Atrial Appendage;   Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 5
Intervention: Device: Left atrial appendage occlusion
29 Recruiting The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Conditions: Patients Undergoing Routine Health Care;   Heart Diseases;   Inflammatory Bowel Diseases;   Autoimmune Disease;   Inflammatory Disease;   Blood Coagulation Disorders;   Hepatitis C;   Non-Metastatic Neoplasm
30 Unknown  The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots
Condition: Blood Coagulation Disorders
Interventions: Device: Levonorgestrel-containing IUD (Mirena®);   Device: Copper-containing IUD (Paraguard®)
31 Unknown  "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
Conditions: Myocardial Ischemia;   Blood Coagulation Disorders;   Coronary Artery Disease;   Heart Valve Diseases
Intervention: Drug: Recombinant Activated Factor VII
32 Not yet recruiting Human Fibrinogen Concentrate in Pediatric Cardiac Surgery
Conditions: Hypofibrinogenemia;   Afibrinogenemia;   Bleeding Disorders
Interventions: Drug: RiaStAP;   Drug: Saline
33 Recruiting Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)
Condition: Hemophilia
34 Recruiting Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
Condition: Severe Hemophilia
35 Not yet recruiting Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
36 Recruiting A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa pegol
37 Recruiting To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
38 Recruiting Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: nonacog beta pegol
39 Recruiting Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa pegol
40 Recruiting Swiss Hemophilia Registry
Condition: Hemophilia and Other Severe Bleeding Disorders
Intervention: Other: Registry

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years